Optimization of Scan Parameters for in vivo Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The aim of this study was to investigate the change in signal sensitivity over different acquisition start times and optimize the scanning window to provide the maximal signal sensitivity of [1-13C]pyruvate and its metabolic products, lactate and alanine, using spatially localized hyperpolarized 3D 13C magnetic resonance spectroscopic imaging (MRSI). Materials and Methods: We acquired 3D 13C MRSI data from the brain (n = 3), kidney (n = 3), and liver (n = 3) of rats using a 3T clinical scanner and a custom RF coil after the injection of hyperpolarized [1-13C]pyruvate. For each organ, we obtained three consecutive 3D 13C MRSI datasets with different acquisition start times per animal from a total of three animals. The mean signal-to-noise ratios (SNRs) of pyruvate, lactate, and alanine were calculated and compared between different acquisition start times. Based on the SNRs of lactate and alanine, we identified the optimal acquisition start timing for each organ. Results: For the brain, the acquisition start time of 18 s provided the highest mean SNR of lactate. At 18 s, however, the lactate signal predominantly originated from not the brain, but the blood vessels; therefore, the acquisition start time of 22 s was recommended for 3D 13C MRSI of the rat brain. For the kidney, all three metabolites demonstrated the highest mean SNR at the acquisition start time of 32 s. Similarly, the acquisition start time of 22 s provided the highest SNRs for all three metabolites in the liver. Conclusion: In this study, the acquisition start timing was optimized in an attempt to maximize metabolic signals in hyperpolarized 3D 13C MRSI examination with [1-13C] pyruvate as a substrate. We investigated the changes in metabolic signal sensitivity in the brain, kidney, and liver of rats to establish the optimal acquisition start time for each organ. We expect the results from this study to be of help in future studies.
Abstract
Purpose: The aim of this study was to investigate the change in signal sensitivity over different acquisition start times and optimize the scanning window to provide the maximal signal sensitivity of [1-13C]pyruvate and its metabolic products, lactate and alanine, using spatially localized hyperpolarized 3D 13C magnetic resonance spectroscopic imaging (MRSI). Materials and Methods: We acquired 3D 13C MRSI data from the brain (n = 3), kidney (n = 3), and liver (n = 3) of rats using a 3T clinical scanner and a custom RF coil after the injection of hyperpolarized [1-13C]pyruvate. For each organ, we obtained three consecutive 3D 13C MRSI datasets with different acquisition start times per animal from a total of three animals. The mean signal-to-noise ratios (SNRs) of pyruvate, lactate, and alanine were calculated and compared between different acquisition start times. Based on the SNRs of lactate and alanine, we identified the optimal acquisition start timing for each organ. Results: For the brain, the acquisition start time of 18 s provided the highest mean SNR of lactate. At 18 s, however, the lactate signal predominantly originated from not the brain, but the blood vessels; therefore, the acquisition start time of 22 s was recommended for 3D 13C MRSI of the rat brain. For the kidney, all three metabolites demonstrated the highest mean SNR at the acquisition start time of 32 s. Similarly, the acquisition start time of 22 s provided the highest SNRs for all three metabolites in the liver. Conclusion: In this study, the acquisition start timing was optimized in an attempt to maximize metabolic signals in hyperpolarized 3D 13C MRSI examination with [1-13C] pyruvate as a substrate. We investigated the changes in metabolic signal sensitivity in the brain, kidney, and liver of rats to establish the optimal acquisition start time for each organ. We expect the results from this study to be of help in future studies.
참고문헌 (22)
- Kurhanewicz J, "Hyperpolarized 13C MRI : path to clinical translation in oncology", Neoplasia, 21, pp.1~16 (2019)
- Ardenkjaer-Larsen JH, "Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR", Proc Natl Acad Sci U S A, 100, pp.10158~10163 (2003)
- Wang ZJ, "Hyperpolarized 13C MRI : state of the art and future directions", Radiology, 291, pp.273~284 (2019)
- Vaeggemose M, "Comprehensive literature review of hyperpolarized carbon-13 MRI : the road to clinical application", Metabolites, 11, pp.219~ (2021)
- Park I, "Development of methods and feasibility of using hyperpolarized carbon-13imaging data for evaluating brain metabolism in patient studies", Magn Reson Med, 80, pp.864~873 (2018)
- Park I, "Evaluation of heterogeneous metabolic profile in an orthotopic human glioblastoma xenograft model using compressed sensing hyperpolarized 3D 13C magnetic resonance spectroscopic imaging", Magn Reson Med, 70, pp.33~39 (2013)
- Park I, "Differentiating radiation necrosis from brain tumor using hyperpolarized carbon-13MR metabolic imaging", Mol Imaging Biol, 23, pp.417~426 (2021)
- Park I, "Correlation of tumor perfusion between carbon-13 imaging with hyperpolarized pyruvate and dynamic susceptibility contrast MRI in pre-clinical model of glioblastoma", Mol Imaging Biol, 21, pp.626~632 (2019)
- Park I, "Changes in pyruvate metabolism detected by magnetic resonance imaging are linked to DNA damage and serve as a sensor of temozolomide response in glioblastoma cells", Cancer Res, 74, pp.7115~7124 (2014)
- Park S, "Characterization of distinctive in vivo metabolism between enhancing and non-enhancing gliomas using hyperpolarized carbon-13MRI", Metabolites, 11, pp.504~ (2021)
- Crane JC, "SIVIC: open-source, standards-based software for DICOM MR spectroscopy workflows", Int J Biomed Imaging, 2013, pp.169526~ (2013)
- Chen J, "Preoperative imaging of glioblastoma patients using hyperpolarized 13C pyruvate : potential role in clinical decision making", Neurooncol Adv, 3, pp.vdab092~ (2021)
- Tran M, "First-in-human in vivo non-invasive assessment of intra-tumoral metabolic heterogeneity in renal cell carcinoma", BJR Case Rep, 5, pp.20190003~ (2019)
- Duwel S, "Multiparametric human hepatocellular carcinoma characterization and therapy response evaluation by hyperpolarized(13)C MRSI", NMR Biomed, 29, pp.952~960 (2016)
- Rui L, "Energy metabolism in the liver", Compr Physiol, 4, pp.177~197 (2014)
- Cho A, "A nonsynthetic approach to extending the lifetime of hyperpolarized molecules using D2O solvation", J Magn Reson, 295, pp.57~62 (2018)
- Gordon JW, "3D hyperpolarized C-13 EPI with calibrationless parallel imaging", J Magn Reson, 289, pp.92~99 (2018)
- Ohliger MA, "Combined parallel and partial fourier MR reconstruction for accelerated 8-channel hyperpolarized carbon-13 in vivo magnetic resonance spectroscopic imaging(MRSI)", J Magn Reson Imaging, 38, pp.701~713 (2013)
- Pedersen H, "k-t PCA : temporally constrained k-t BLAST reconstruction using principal component analysis", Magn Reson Med, 62, pp.706~716 (2009)
- Wespi P, "Highresolution hyperpolarized metabolic imaging of the rat heart using k-t PCA and k-t SPARSE", NMR Biomed, 31 (2018)
- Qiao K, "Non-invasive differentiation of M1 and M2 activation in macrophages using hyperpolarized 13C MRS of pyruvate and DHA at 1.47Tesla", Metabolites, 11, pp.410~ (2021)
- fumarate enables magnetic resonance-based imaging of myocardial necrosis, "JACC Cardiovasc Imaging", 2018, 1594~1606